SCHEMBL22858086

SCHEMBL22858086

c1ccc(-c2cccc(-c3ccc4c(c3)c3cccc5c6c7ccccc7ccc6n4c35)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.35
CDK4 P11802 2/20 0.35
CCND1 P24385 2/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
CYP1A1 P04798 2/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
AHR P35869 1/20 0.34
PAX8 Q06710 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
CYP1B1 Q16678 1/20 0.34
TSPO P30536 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
NPY1R P25929 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21718136 0.99 PTGES (0.34) PTGESCDK4CCND1HSD17B1HSD17B2
SCHEMBL21718134 0.99 PTGES (0.35) PTGESCDK4CCND1HSD17B1HSD17B2
SCHEMBL22858105 0.99 PTGES (0.35) PTGESCDK4CCND1HSD17B1HSD17B2
SCHEMBL22679268 0.90 PTGES (0.34) PTGESHSD17B1HSD17B2CYP1A1CYP1A2
SCHEMBL21710485 0.90 HPRT1 (0.36) PTGESHSD17B1HSD17B2CYP1A1CYP1A2
SCHEMBL21718104 0.89 KDM4E (0.35) PTGESCDK4CCND1CYP1A1CYP1A2
SCHEMBL21710590 0.89 CYP1A2 (0.38) PTGESHSD17B1HSD17B2CYP1A1CYP1A2
SCHEMBL21710591 0.88 PTGES (0.33) PTGESCDK4CCND1CYP1A2FYN
SCHEMBL21710477 0.88 PTGES (0.34) PTGESCDK4CCND1CYP1A1CYP1A2
SCHEMBL21710703 0.87 CCR4 (0.36) PTGESHSD17B2ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 PTGES 4031/4885CDK4 854/4885CCND1 57/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 PTGES 4447/4885CDK4 2517/4885CCND1 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.